Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Ogata T; Tanaka H; Kon A; Sakaibori N; Tanaka E
  • المصدر:
    Emerging infectious diseases [Emerg Infect Dis] 2024 Jul; Vol. 30 (7), pp. 1430-1433.
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
    • الموضوع:
    • نبذة مختصرة :
      We calculated attack rates for household contacts of COVID-19 patients during the SARS-CoV-2 Omicron BA.2-dominant period in Japan. Attack rates among household contacts without recent (<3 months) vaccination was lower for contacts of index patients with complete vaccination than for contacts of index patients without complete vaccination, demonstrating indirect vaccine effectiveness.
    • References:
      Int J Environ Res Public Health. 2022 Jun 30;19(13):. (PMID: 35805724)
      Vaccine. 2023 May 11;41(20):3292-3300. (PMID: 37085456)
      Nat Commun. 2023 Sep 6;14(1):5452. (PMID: 37673865)
      Nat Med. 2023 Feb;29(2):358-365. (PMID: 36593393)
      Int J Infect Dis. 2023 Sep;134:200-206. (PMID: 37356650)
      Nat Commun. 2022 Sep 30;13(1):5760. (PMID: 36180438)
    • Contributed Indexing:
      Keywords: BA.2; COVID-19; COVID-19 vaccines; Contact tracing; Japan; Omicron; SARS-CoV-2; SARS-CoV-2 variants; attack rate; coronavirus; coronavirus disease; household contact; incidence; infectiousness; respiratory diseases; risk factors; vaccine effectiveness; vaccine efficacy; viruses; zoonoses
    • الرقم المعرف:
      0 (COVID-19 Vaccines)
    • الموضوع:
      SARS-CoV-2 variants
    • الموضوع:
      Date Created: 20240625 Date Completed: 20240625 Latest Revision: 20240702
    • الموضوع:
      20240702
    • الرقم المعرف:
      PMC11210665
    • الرقم المعرف:
      10.3201/eid3007.230968
    • الرقم المعرف:
      38916601